Dudediligence.

Maze Therapeutics, Inc

MAZENASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$25.7M

23 notices · 741,288 sh

Oct 2025 to Oct 2026

Reported ·

$15.9M

57 sales · 0 buys

Oct 2025 to Jun 2026

The two figures cover different periods.

55 of 57 reported sales carry the 10b5-1 box. Together they are 0.77% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-10-01: Coloma Jason V, Form 1442026-10-01: HAROLD BERNSTEIN, Form 1442026-09-04: HAROLD BERNSTEIN, Form 1442026-09-02: Harold Bernstein, Form 1442026-09-02: Atul Dandekar, Form 1442026-09-02: Courtney Phillips, Form 1442026-09-02: Jason V Coloma, Form 1442026-09-01: Coloma Jason V, Form 1442026-08-03: Coloma Jason V, Form 1442026-07-29: ATUL DANDEKAR, Form 1442026-07-01: Coloma Jason V, Form 1442026-07-01: HAROLD BERNSTEIN, Form 1442026-06-01: Coloma Jason V, Form 1442026-05-15: Coloma Jason V, Form 1442026-03-30: ATUL DANDEKAR, Form 1442026-03-10: HAROLD BERNSTEIN, Form 1442026-01-16: SEKAR KATHIRESAN, Form 1442026-01-07: CATHERINE SOHN, Form 1442026-01-06: CATHERINE SOHN, Form 1442025-12-29: HAROLD BERNSTEIN, Form 1442025-12-29: ATUL P DANDEKAR, Form 1442025-12-04: SEKAR KATHIRESAN, Form 1442025-11-21: SEKAR KATHIRESAN, Form 1442025-12-29: Dandekar Atul, sold2025-12-29: Bernstein Harold, sold2025-12-29: Bachrodt Amy, sold2026-01-02: Bernstein Harold, sold2026-01-02: Bachrodt Amy, sold2026-01-06: Sohn Catherine A., sold2026-01-07: Bernstein Harold, sold2026-01-22: Bachrodt Amy, sold2026-01-29: Dandekar Atul, sold2026-02-02: Bernstein Harold, sold2026-02-02: Bachrodt Amy, sold2026-02-27: Dandekar Atul, sold2026-03-02: Bachrodt Amy, sold2026-03-10: Bernstein Harold, sold2026-03-20: Bernstein Harold, sold2026-03-30: Dandekar Atul, sold2026-04-01: Bernstein Harold, sold2026-04-01: Bachrodt Amy, sold2026-04-29: Dandekar Atul, sold2026-05-14: Bernstein Harold, sold2026-05-15: Coloma Jason V, sold2026-05-22: Coloma Jason V, sold2026-05-29: Dandekar Atul, sold2026-06-01: Coloma Jason V, sold2026-06-01: Bernstein Harold, sold2026-06-22: Coloma Jason V, sold
under a no plan named▼ salesize is dollars

Form 144 notices, newest first

2026-10-01Coloma Jason V, Chief Executive Officer$933,252
34,501 shplan 2026-02-06Form 4s on file end Jun 23144 ↗
2026-10-01HAROLD BERNSTEIN, President, R&D & CMO$438,712
16,141 shplan 2025-09-29Form 4s on file end Jun 23144 ↗
2026-09-04HAROLD BERNSTEIN, President, R&D & CMO$251,068
9,705 shplan 2025-09-29Form 4s on file end Jun 23144 ↗
2026-09-02Harold Bernstein, President, R&D & CMO$283,500
10,685 shplan 2025-09-29Form 4s on file end Jun 23144 ↗
2026-09-02Atul Dandekar, CSBO$177,200
6,679 shplan 2025-09-29Form 4s on file end Jun 23144 ↗
2026-09-02Courtney Phillips, GC and Corp. Secretary$110,000
4,144 shno plan dateForm 4s on file end Jun 23144 ↗
2026-09-02Jason V Coloma, Chief Executive Officer$623,400
23,497 shplan 2026-02-06Form 4s on file end Jun 23144 ↗
2026-09-01Coloma Jason V, Chief Executive Officer$908,066
34,501 shplan 2026-02-06Form 4s on file end Jun 23144 ↗
2026-08-03Coloma Jason V, Chief Executive Officer$922,557
34,501 shplan 2026-02-06Form 4s on file end Jun 23144 ↗
2026-07-29ATUL DANDEKAR, CSBO$627,300
22,500 shplan 2025-09-29Form 4s on file end Jun 23144 ↗
2026-07-01Coloma Jason V, Chief Executive Officer$1,034,254
34,501 shplan 2026-02-06Form 4s on file end Jun 23144 ↗
2026-07-01HAROLD BERNSTEIN, President, R&D & CMO$1,399,257
46,892 shplan 2025-09-29Form 4s on file end Jun 23144 ↗
2026-06-01Coloma Jason V, Chief Executive Officer$908,066
34,501 shplan 2026-02-06144 ↗
Form 4, 2026-06-03: sold 6,643 at $26.20 Form 4 ↗
2026-05-15Coloma Jason V, Chief Executive Officer$895,327
34,502 shplan 2026-02-10144 ↗
Form 4, 2026-05-18: sold 1,938 at $26.00 Form 4 ↗
2026-03-30ATUL DANDEKAR, CSBO$911,400
30,000 shplan 2025-09-29144 ↗
Form 4, 2026-04-01: sold 7,500 at $29.34 Form 4 ↗
2026-03-10HAROLD BERNSTEIN, President, R&D & CMO$3,372,876
74,853 shplan 2025-09-29144 ↗
Form 4, 2026-03-12: sold 30,000 at $50.46 Form 4 ↗
2026-01-16SEKAR KATHIRESAN, Former Director$1,210,937
29,772 shno plan dateno Form 4 on file144 ↗
2026-01-07CATHERINE SOHN, Director$1,052,785
26,920 shno plan dateno Form 4 on file144 ↗
2026-01-06CATHERINE SOHN, Director$96,270
2,493 shno plan date144 ↗
Form 4, 2026-01-08: sold 29,413 at $39.07 Form 4 ↗
2025-12-29HAROLD BERNSTEIN, President, R&D & CMO$4,420,500
105,000 shplan 2025-09-29144 ↗
Form 4, 2025-12-31: sold 45,000 at $40.57 Form 4 ↗
2025-12-29ATUL P DANDEKAR, CSBO$3,683,750
87,500 shplan 2025-09-29144 ↗
Form 4, 2025-12-31: sold 72,500 at $40.56 Form 4 ↗
2025-12-04SEKAR KATHIRESAN, Former Board Member$425,423
10,000 shno plan dateno Form 4 on file144 ↗
2025-11-21SEKAR KATHIRESAN, Former Board Member$984,588
27,500 shno plan dateno Form 4 on file144 ↗